Approach to the Triple Negative Breast Cancer in New Drugs Area
Triple negative breast cancers (TNBCs) are associated with aggressive course, higher rates of visceral and central nervous system metastases and lower survival rate than hormone receptor positive. Once metastasis has occurred, a median survival was approximately one year. Currently, chemotherapy in...
Main Author: | |
---|---|
Format: | Article |
Language: | English |
Published: |
Tehran University of Medical Sciences
2016-04-01
|
Series: | International Journal of Hematology-Oncology and Stem Cell Research |
Subjects: | |
Online Access: | https://ijhoscr.tums.ac.ir/index.php/ijhoscr/article/view/555 |